INTRODUCTION
============

Gauderer et al^[@B1]^ first described the technique of percutaneous endoscopic gastrostomy (PEG) in 1980. It was originally introduced as an alternative method to conventional open surgical gastrostomy for nutritional support in patients with head and neck cancer. It is considered to be a safer procedure, with a lower complication rate, is less invasive, generally well tolerated, and more cost effective.^[@B2]^ Percutaneous endoscopic gastrostomy has been shown to improve nutritional status and the quality of life in these patients.^[@B3]--[@B5]^

Complications of percutaneous endoscopic gastrostomy are relatively uncommon, but include local infection, hemorrhage, dislodgment, peritonitis, bowel perforation, and aspiration pneumonia.^[@B6]^ Another rare complication that appears to be becoming more prevalent is the meta-static implantation of tumor at the PEG tube site. The first case of gastric and abdominal wall metastasis secondary to PEG placement in a patient with head and neck cancer was reported in 1989.^[@B7]^ Since then, 29 similar cases of tumor implantation at the PEG site have been reported. We report another case of tumor implantation at the PEG site from squamous cell cancer (SCC) of the head and neck. A review of the literature helped to determine the possible mechanism of spread.

CASE REPORT
===========

The patient is a 59-year-old male with a history of alcoholism and tobacco abuse. In March 2004, he was diagnosed with a (T4N2M0) Stage IV squamous cell carcinoma (SCC) of the right soft palate, tonsilllar fossa, retromolar trigone, and base of the tongue. He underwent wide resection that included half of the soft palate, the tonsillar region, the retromolar trigone, and about 40% of the base of the tongue. He also underwent a modified neck dissection. To cover the defect, a skin/subcutaneous free flap from the abdomen was utilized. A tracheostomy and PEG tube placement were performed at the time of the original surgery. Postoperatively, the patient had problems with delirium tremens but was able to be discharged on day 7 tolerating tube feedings. All surgical margins were free of tumor involvement. The patient had 2 positive nodes in the right neck, 1 with extracapsular spread, and both lymphovascular and perineural invasion had occurred within the specimen. The patient subsequently underwent 34 treatments of radiation therapy (XRT).

In April 2004, the patient also underwent mandibular odontectomy, alveolectomy, and minor revision of the free flap at the alveolar process. Close to 1 month after insertion of the PEG tube, the patient stated he noticed some granulation tissue forming around the tube site. This progressed rapidly, but the patient neglected to seek medical attention. In July 2004, the patient was referred by his family practitioner with a large 4-cm fungating mass around his tube site. Within 3 weeks, the mass reached a size of 9 cm in diameter **([Figure 1](#F1){ref-type="fig"})**. An incisional biopsy was obtained that revealed SCC, and it was felt that this came from the patient\'s original head and neck cancer. Upper endoscopy was performed that showed the tumor around the bumper or mushroom within the stomach **([Figure 2](#F2){ref-type="fig"})**. Further evaluation by computed tomography (CT) showed a large mass extending through the abdominal wall **([Figure 3](#F3){ref-type="fig"})**. Metastatic workup to include CT of the head, neck, chest, and abdomen were negative, except for the mass in the abdominal wall and stomach. Radiation-oncology consultation was obtained, and the patient subsequently received 4500 rads, 25 fractions to the abdominal wall. A significant reduction in the size of the mass was obtained. Several weeks later following radiation therapy, the patient had a CT scan that did not show any residual disease. An en bloc resection of the abdominal wall around the PEG to include a wedge re-section of the stomach was performed. Margins were clear, and no residual tumor was detected. The abdominal wall was repaired with Dual Mesh. The patient was discharged 5 days later tolerating a soft puree diet. The patient did well initially; on follow-up, however, exactly 1 year later, from the time of the patient\'s original head and neck surgery, he developed local recurrence to the jaw. The patient is presently in hospice care.

![Large exophytic lesion around the percutaneous endoscopic gastrostomy tube.](jsls-9-4-466-g01){#F1}

![Endoscopically visible tumor around the percutaneous endoscopic gastrostomy tube bumper.](jsls-9-4-466-g02){#F2}

![Computed tomographic scan of the abdomen revealing transabdominal extent of the tumor.](jsls-9-4-466-g03){#F3}

DISCUSSION
==========

Since its introduction in 1980, PEG has become increasingly popular after surgery, and radiotherapy for improving patient\'s nutritional status and reducing the duration of the hospital stay.^[@B1]^ It is also the preferred method for feeding patients with severe facial trauma and dysphagia as a result of advanced neurological disease and more recently has been used successfully in patients who require prolonged gastrointestinal decompression.^[@B2]^ Surgical or open gastrostomy has the disadvantage of requiring a laparotomy, and most studies have shown it to be associated with more complications than PEG.^[@B8],[@B9]^

Several methods have been described for the percutaneous endoscopic insertion of the gastrostomy tube, of which the Ponski-Gauderer pull method is the most widely used.^[@B1]^ The pull-through method involves passing the endoscope through the mouth into the stomach. An angiocatheter is introduced through the abdominal wall into the insufflated stomach under direct visualization. A wire is then passed through the angiocatheter, snared endoscopically, and pulled through the patient\'s mouth. The gastrostomy tube is then attached to the end of the wire and pulled back through the mouth and esophagus into the stomach and out through the abdominal wall. Another less popular technique, known as the "push-through" or "introducer" technique uses the Seldinger method to directly place the tube through the abdominal wall into the stomach that has been insufflated by way of the esophagus.^[@B10]^ This technique does not require passage of the gastrostomy tube over the pharynx.

The reported complication rate for PEG is about 5% compared with about 10% for open gastrostomy, and the reported procedure-related mortality rate is less than 1% compared with about 4% for open gastrostomy.^[@B8],[@B9]^ Complications of PEG include aspiration pneumonia and airway compromise, hemorrhage, tube dislodgement, abdominal wall infection, intraperitoneal leakage and peritonitis, gastroesophageal reflux, dyspnea, transient pneumoperitoneum, tube blockage, pain and infection around the tube site, and formation of granulation tissue.^[@B2]^ A rare but increasingly reported complication in patients with head and neck cancer is the metastatic spread of SCC to the PEG tube site.

The reported incidence of metastatic neoplasms to the stomach have been 0.7% to 2%.^[@B11]--[@B13]^ In autopsy findings by Antler et al,^[@B14]^ the incidence of lung cancer metastasizing to the stomach was as high as 9%.

The spread of cancer to a gastrostomy stoma was first reported in 1971 by Alagaratnam,^[@B15]^ who performed the procedure in an open manner. Since 1989, 29 cases have been reported of metastatic seeding from the upper aerodigestive tract to the PEG site. A total of 29 of these patients including our patient had squamous cell carcinoma and 1 had adenocarcinoma **([Table 1](#T1){ref-type="table"})**.^[@B2],[@B7],[@B15]--[@B39]^

###### 

Cases of Metastasis to Gastrostomy Site

  Reference                  Cancer Histology and Stage   Primary Tumor Location     Insertion Method   Metastasis Interval (mos.)   Concurrent Metastasis
  -------------------------- ---------------------------- -------------------------- ------------------ ---------------------------- --------------------------
  1977 Alagaratnam^[@B15]^   SCC, 4                       Oropharynx, Larynx         Open               24                           None
  1989 Preyer^[@B7]^         SCC, 4                       Nasopharynx                Pull               3                            Lungs
  1991 Bushnell^[@B30]^      SCC, 4                       Larynx, Lungs              Pull               15                           Skin
  1992 Huang^[@B31]^         SCC, 4                       Oropharynx, Larynx         Pull               6                            Not reported
  1993 Heinbokel^[@B16]^     Adenoca, 4                   Gastric cardia esophagus   Pull               2                            Not reported
  1993 Laccourreye^[@B20]^   SCC, 4                       Hypopharynx                Pull               11                           Liver
  1993 Massoun^[@B32]^       SCC, 4                       Oropharynx                 Pull               4                            Lungs
  1993 Meurer^[@B29]^        SCC, 4                       Oropharynx, Larynx         Pull               12                           Lungs
  1993 Meurer^[@B29]^        SCC, 4                       Oropharynx                 Pull               15                           Lungs
  1994 Schiano^[@B33]^       SCC, 4                       Hypopharynx                Pull               4                            Not reported
  1994 Sharma^[@B18]^        SCC, 4                       Oropharynx                 Pull               6                            None
  1995 Becker^[@B34]^        SCC, 4                       Hypopharynx                Pull               3                            Lungs
  1995 Becker^[@B34]^        SCC, 3                       Cervical Esophagus         Pull               5                            Local relapse
  1995 Lee^[@B27]^           SCC, 4                       Oropharynx                 Pull               13                           Gastric ligaments
  1998 Van-Erpecum^[@B21]^   SCC, 4                       Hypopharynx                Pull               2--10                        None
  1995 Wilson^[@B35]^        SCC, 4                       Hypopharynx                Pull               Not reported                 Not reported
  1997 Schneider^[@B22]^     SCC, 4                       Oropharynx                 Pull               10                           None
  1997 Thorburn^[@B23]^      SCC, 4                       Hypopharynx, Larynx        Pull               11                           Not reported
  1998 Potochny^[@B19]^      SCC, 4                       Hypopharynx                Pull               9                            None
  1999 Deinzer^[@B36]^       SCC, 3                       Proximal Esophagus         Pull               3                            Not reported
  1999 Hosseini^[@B37]^      SCC, 2/3                     Distal Esophagus           Pull               2                            None
  2000 Brownl^[@B7]^         SCC, 3                       Mid Esophagus              Pull               9                            Lungs, spine
  2000 Peghini^[@B38]^       SCC, 4                       Tongue                     Pull               9                            Skin, Colon, Bone
  2000 Douglas^[@B25]^       SCC, 4                       Tonsillar Fossa            Pull               3.6                          None
  1996 Lauvin^[@B39]^        SCC, 4                       Esophagus                  Pull               4                            Not reported
  2001 Sinclair^[@B28]^      SCC, 3                       Tongue                     Pull               5                            Axillary Nodes
  2001 Cossentino^[@B26]^    SCC, 4                       Tongue                     Pull               8                            Lung
  2001 Cossentino^[@B26]^    SCC, 2                       Tongue                     Pull               9                            None
  2002 Anath^[@B2]^          SCC, 4                       Floor of mouth             Pull               3                            None
  2003 Thakore^[@B24]^       SCC, 4                       Larynx                     Pull               Unable to determine          Lungs, Bone, Skin, Brain
  2005 Mincheff              SCC, 4                       Oropharynx                 Pull               1                            None

SCC = small cell carcinoma.

It appears that the pull method was used in all these cases. In our case, the patient described tumor developing around the PEG tube 1 month after insertion, but the mean time to PEG site implantation in previously reported cases was 8 months (range, 2 to 17). It is also interesting to note that almost all cases involved advanced (Stage III, IV) SCC of the head and neck region. The exception to that is an adenocarcinoma of the distal esophagus.^[@B16]^

Various theories exist concerning the mechanism of spread of the tumor to the PEG site, which include the direct implantation at the time of PEG placement, hematogenous or lymphatic spread, and the possibility of shedding of tumor cells into the gastrointestinal tract from the original head and neck cancer. No controlled experiments have been done to determine whether a particular PEG technique or simply the trauma secondary to the gastrostomy is responsible.^[@B24]^

One hypothesis is that the pull method that was used in all reportable cases may implant or seed malignant cells along the path where instruments have injured the tissue.

Tumor cells from the oropharynx coat and contaminate the bumper of the PEG tube as it is pulled through. This theory is also supported by cases reported by Sharma et al^[@B18]^ and Potochny et al,^[@B19]^ as well as others **([Table 1](#T1){ref-type="table"})**.^[@B20]--[@B23],[@B27]^

In an effort to clarify the mechanism of spread, Douglas et al used a tumor kinetic model and concluded that direct implantation of cells is more likely than hematogenous spread in patients whose metastasis appears within 12 months of PEG placement.^[@B25],[@B26]^ In a review of cases since 1989, it was noted that a substantial proportion of patients had PEG metastasis develop at a very short interval after the procedure, as early as 2 months.^[@B25]^ Our patient noticed the tumor within 1 month but failed to seek medical attention.

A study by Kodama et al^[@B40]^ reported that surgical stress might cause an increase in tumor metastasis because high levels of serum cortisol after a surgical procedure may induce morphological changes, both in the capillary lumen and on the tumor cell surface, that may facilitate retention of tumor cells. These results are consistent with the possibility that direct implantation causes tumor metastasis.^[@B28]^

Another theory is that metastasis at the gastrostomy stomata is related to either hematogenous or lymphatic spread of tumor cells.^[@B17],[@B26],[@B29],[@B41],[@B42]^ This hypothesis is in agreement with accepted ideas regarding the mechanism of cancer metastasis.^[@B43]^ In the majority of cases, the primary tumor had known lymph node invasion (before gastrostomy tube placement), and in over half the cases, distant metastases were discovered previously or concurrently with the stomal metastasis.^[@B17]^ This implies that tumor cells were circulating in the lymphatic channels and blood stream.

CONCLUSION
==========

The exact mechanism of gastric and abdominal wall metastasis in patients with PEG placement still remains unclear and controversial. Since 1989, almost every year a case of metastatic implantation at the PEG tube site for head and neck cancer has been reported. PEG placement by the pull method appears to remain the preferred or standard procedure for patients with head and neck cancer in spite of the overwhelming evidence not to use this method. Special precautions must be taken during the procedure to minimize the disruption of tumor cells. It is our suggestion that an alternative to the pull method should be considered in this select group of patients.
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